• Home
  • About
  • ‘Enforcement 40’ for 2020
  • Webcasts
  • Enforcement Hall of Fame
  • Contact
Securities Docket
Ankura 480x60
  • Class Actions
  • Criminal
  • Global
  • People
  • SD Insider
  • SEC
  • Video
  • Subscribe by email
  • Subscribe
Browse: Home / 2014 / August / 08 / Securities Litigation Surges Against Biotech Companies — The Recorder

Securities Litigation Surges Against Biotech Companies — The Recorder

By Securities Docket on August 8, 2014, 9:58 am

An overall slump in securities class action litigation has continued in the first six months of 2014, according to a report from Cornerstone Research. But the outlook is less rosy for the biotech sector, which was hit with twice as many suits as in the two previous six-month periods.

via Securities Litigation Surges Against Biotech Companies — The Recorder

Blog Widget by LinkWithin

Posted in Class Actions, Top | Tagged Biotech, Reports

« Previous Next »

Subscribe

‘Enforcement 40’ for 2020

Securities-Docket_Medium-Rectangle_CaseStudyArrow

Our Sponsors

Securities-Docket_260x125_14Sec Ankura 260x125

Join Us On LinkedIn

Join the Securities Litigation and Enforcement Group on LinkedIn

Archives

Copyright © 2022 Securities Docket.

Powered by WordPress and Hybrid.